Dec 23 LGBT advocates say FDA gay blood donor policy revision is long overdue, but ‘not enough’ By Joshua Barajas The FDA said in a statement that it will "recommend a change to the blood donor deferral period for men who have sex with men from indefinite deferral to one year since the last sexual contact."… Continue reading
Dec 23 FDA targeting sellers of pure caffeine powder By Mary Clare Jalonick, Associated Press The Food and Drug Administration is building a legal case against companies that sell pure powdered caffeine, which can be fatal even in small doses. The FDA warned consumers to avoid pure powdered caffeine this summer after the death of… Continue reading
Nov 25 Watch Will labeling calorie counts on menus bring down America’s obesity rates? By PBS News Hour Food chains, including restaurants, cafes and even some vending machines, will soon be required to list calorie counts clearly on their menus. Margaret Hamburg of the FDA, the group responsible for the new law, speaks with Judy Woodruff on the… Continue watching
Nov 25 New FDA rules will require calorie counts in food establishments By Mary Clare Jalonick, Associated Press WASHINGTON — Whether they want to or not, consumers will soon know how many calories they are eating when ordering off the menu at chain restaurants, picking up prepared foods at supermarkets and even eating a tub of popcorn at… Continue reading
Sep 14 FDA considers ban on electric shock devices used to curb self-harm By Lauran Neergaard, Associated Press Self-injury is one of the most difficult behaviors associated with autism and other developmental or intellectual disabilities, and a private facility outside Boston that takes on some of the hardest-to-treat cases is embroiled in a major debate: Should it use… Continue reading
Aug 05 New FDA ‘gluten-free’ regulation rolls out By Anna Christiansen Starting this week, all food products marked as “gluten-free” can only make the claim if they contain less than 20 parts per million of gluten. Continue reading
Jul 26 FDA will consider approval of biosimilar drug for first time By Hannah Yi Americans are a small step closer to accessing less-expensive specialty drugs known as biologics. The Food and Drug Administration for the first time accepted an application for the approval of a copycat “generic” version of the brand name drug Neupogen,… Continue reading
Jul 24 Are drug companies using safety rules to block generic competition? By Megan Thompson A new study claims pharmaceutical companies may be misusing FDA safety guidelines to block generic drugs from market, costing the health care system more than $5 billion dollars a year. Continue reading
Jul 07 FDA regulation can’t keep pace with new mobile health apps By Joshua Barajas Although lawmakers have repeatedly called on Congress to create a special office within the FDA to regulate health apps available in the mobile marketplace, the idea was rejected at a roundtable discussion on medical device security in… Continue reading